Pacira BioSciences paid its 8 named executives $32.2M in total in FY2024 (Dec). CEO Frank Lee was paid $15.9M of that.
Pay$100 in the stock at the end of FY23 → $56
Pay of each named executive
Frank LeeChief Executive Officer
| FY2024 (Dec) |
1 year
Kristen WilliamsChief Administrative Officer and Secretary
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
Daryl GauglerExecutive Vice President, Commercial Operations
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed |
3 years
Jonathan SloninChief Medical Officer
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
Shawn CrossChief Financial Officer
| FY2024 (Dec) |
1 year
Lauren RikerFormer Interim Chief Financial Officer
| FY2024 (Dec) |
1 year
Charles A. Reinhart, IIIFormer Chief Financial Officer
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
David StackFormer Chief Executive Officer
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
CEO pay against the pay peers
In FY2023 (Dec), the median CEO pay of the 8 peers with pay on file was $10.6M. The CEO of Pacira BioSciences was paid $6.9M, 35% below the median.
- 1United Therapeutics
- 2Ultragenyx Pharmaceutical
- 3Ionis Pharmaceuticals
- 4Halozyme Therapeutics
- 5Alkermes plc.
- 6PTC Therapeutics
- 7Travere Therapeutics
- 8Pacira BioSciencesThis company
- 9CareDx
- 10Acadia PharmaceuticalsNot disclosed
- 11Amicus Therapeutics, Inc.Not disclosed
- 12Blueprint Medicines CorporationNot disclosed
- 13Corcept TherapeuticsNot disclosed
- 14Dynavax Technologies Corporation [img:ic_plus-pn]Not disclosed
- 15Emergent BioSolutions, Inc.Not disclosed
- 16ExelixisNot disclosed
- 17Ironwood Pharmaceuticals, Inc.Not disclosed
- 18Natera, Inc. [img:ic_plus-pn]Not disclosed
- 19Organogenesis Holdings, Inc.Not disclosed
- 20Sarepta Therapeutics, Inc. [img:ic_plus-pn]Not disclosed
- 21Supernus PharmaceuticalsNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.